Tipiracil is a thymidine phosphorylase inhibitor used as an oral antineoplastic agent in combination therapy for the treatment of unresectable advanced or recurrent colorectal cancer. This category contains… Read more
















Tipiracil is a thymidine phosphorylase inhibitor used as an oral antineoplastic agent in combination therapy for the treatment of unresectable advanced or recurrent colorectal cancer. This category contains reference standards essential for analytical testing and quality control of the active pharmaceutical ingredient. Laboratories rely on these high-quality compounds, including specific synthetic impurities and related degradation products, to support rigorous impurity profiling and method development. Stable isotope labelled compounds of Tipiracil are also available, serving as critical internal standards for accurate quantification in complex matrices during mass spectrometry-based bioanalytical assays. The inclusion of pharmacopeial and non-pharmacopeial impurities facilitates comprehensive validation of analytical procedures, ensuring compliance with strict regulatory standards throughout the drug development and manufacturing lifecycle.